The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Villard C, Widman L, Sparrelid E, Bergquist A, et al. Scand J Gastroenterol 2024 Oct 9:1-3. doi: 10.1080/00365521.2024.2412735.

Read + Share

Amedeo Smart

Independent Medical Education

Villard C, Widman L, Sparrelid E, Bergquist A, et al. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol 2024 Oct 9:1-3. doi: 10.1080/00365521.2024.2412735.
PMID: 39381919